Cosentyx unoready 300 MG pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FT5JH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $69,527
Award facts
- Contract value 100% obligated
- $69,526.79 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerSourceBergen Drug Corp, a subsidiary of Cencora, Inc., for Cosentyx (secukinumab) Unoready 300 mg pen 2 mL pharmaceutical supplies. This $69,526.79 firm fixed-price delivery order was awarded on January 12, 2026, with an ultimate completion date of January 13, 2026, and will be performed at the vendor's Conshohocken, Pennsylvania facility. The award utilized no set-aside designation, indicating the contract was competitively awarded on a full and open basis. This delivery order is a task order under AmerSourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerSourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving military and veteran healthcare systems through the Defense Logistics Agency. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse pharmaceutical supply requirements, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. This specific delivery order for Cosentyx, a biologic immunosuppressant medication used to treat autoimmune conditions, reflects the company's role in providing essential pharmaceutical commodities to support military treatment facilities and government healthcare institutions.
Quick answers
Who was awarded contract SPE2DR26FT5JH?
SPE2DR26FT5JH was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26FT5JH worth?
The government has obligated $69,527 on SPE2DR26FT5JH.
Is contract SPE2DR26FT5JH an order under another contract?
Yes. SPE2DR26FT5JH is a delivery order under SPE2DR25D3201, an indefinite delivery contract.
Was contract SPE2DR26FT5JH competed?
The extent of competition for SPE2DR26FT5JH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award